Across TCGA pan-cancer cohorts, ZNF849P RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of ZNF849P’s most consistent transcriptional readouts.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where ZNF849P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ZNF849P is over-expressed in tumor, although a few such as COAD and LUSC show the opposite, repressed pattern.
UCEC, KIRP, and BRCA are the cancer types where ZNF849P tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ZNF849P RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.